FNBT
IPXL

FineMark National Bank & Trust’s Impax Laboratories, Inc. IPXL Stock Holding History

FineMark National Bank & Trust’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-41
Closed -$1K – 1538
2015
Q3 		$1K Buy
+41
New +$1.85K ﹤0.01% 1480

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FineMark National Bank & Trust's IPXL Position: Q4 2015 in Review

FineMark National Bank & Trust sold out of Impax Laboratories, Inc. (IPXL) in Q4 2015, closing a stake of 41 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in IPXL in Q3 2015 and held it in 1 quarter. The position peaked at $1K in Q3 2015. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

  • FineMark National Bank & Trust reported no remaining Impax Laboratories, Inc. position as of Q4 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 41 Impax Laboratories, Inc. shares in Q4 2015, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in Impax Laboratories, Inc. in Q3 2015 and held it in 1 quarter.
  • FineMark National Bank & Trust's Impax Laboratories, Inc. position peaked at $1K in Q3 2015.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.